Biotech componentsMicrobe

Products 1 to 10 of 16

Alternative Protein by Motif Ingredients
Biotech components: Microbe
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/04/01 10:01 (6 years ago)
Date last modified: 2019/04/01 10:01 (6 years ago)
Known funding amount: 90,000,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Bacterial Cellulose produced by Microorganisms by Chinese Academy of Sciences
Biotech components: Bacteria + Enzyme + Microbe
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 09:55 (5 years ago)
Date last modified: 2020/02/10 09:55 (5 years ago)
Known funding amount: N/A
Funding types: Government + Research Institution + University
Industry: Industrial + Medical + Science
Market status: Early Stage Concept
Organization type(s): Research Institution + University
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
Bio-DEM™ by Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components: Enzyme + Gene Editing + Microbe + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:33 (5 years ago)
Date last modified: 2019/09/12 14:33 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment + Venture Capital
Industry: Industrial + Multipurpose
Market status: On the market
Organization type(s): Private Company
Product categories: Additive + Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Microbe
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:18 (5 years ago)
Date last modified: 2019/09/12 15:18 (5 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: On the market
Organization type(s): Private Company
Product categories: Medical Treatment + Medicine
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Microbe
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 3,498,401 USD
Funding types: Government
Industry: Science
Market status: Early Stage Concept
Organization type(s): University
Product categories: Research
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Platform
Micro-algae fatty acids by Flinders University
Biotech components: Microbe
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (4 years ago)
Date last modified: 2020/12/18 14:39 (4 years ago)
Known funding amount: N/A
Funding types: University
Industry: Food & Agriculture + Health
Market status: Early Stage Concept
Organization type(s): University
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Microbial Fuel Cells by Lebônê
Biotech components: Microbe
Business models: B2C
Country of production: South Africa
Country of distribution: Namibia
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/05/15 15:40 (5 years ago)
Known funding amount: 300,000 USD
Funding types: Development Bank + Foundation
Industry: Industrial
Market status: Early Stage Concept + No longer on the market
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
ON Technology by Pivot Bio
Biotech components: Microbe
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:36 (6 years ago)
Known funding amount: 16,700,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Soil Amendment
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Pivot Bio PROVEN by Pivot Bio
Biotech components: Microbe
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/02/10 10:00 (5 years ago)
Date last modified: 2020/02/10 10:00 (5 years ago)
Known funding amount: 86,700,000 USD
Funding types: Venture Capital
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Soil Amendment
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Resveratrol by Evolva
Biotech components: Microbe
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Food + Personal Care (Topical) + Personal Care (Ingested)
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input